PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION

PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION

Anemia is an integral component of CKD. The prescribing of erythropoiesis stimulating agents (ESA) for the treatment of anemia constitutes a significant burden on health budgets. Using of continuous erythropoietin receptor activator (CERA) and convective techniques can improve health indicators and...

Full description

Bibliographic Details
Main Author:	V. Novakivskyy
Format:	Article
Language:	English
Published:	State Institution «Institute of Nephrology NAMS of Ukraine" 2017-03-01
Series:	Український Журнал Нефрології та Діалізу
Subjects:	anemia, hemoglobin, hemodialysis, hemodiafiltration, continuous erythropoiesis receptor activator
Online Access:	https://ukrjnd.com.ua/index.php/journal/article/view/217

Similar Items

Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
by: Maciej Drozdz, et al.
Published: (2019-01-01)

Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study
by: Soo Ya Bae, et al.
Published: (2019-08-01)

Influence of Dialysis Modality on the Treatment of Anemia in Patients with End-Stage Kidney Disease
by: Hamzagic Nedim, et al.
Published: (2020-09-01)

Hemodiafiltration Improves Plasma 25-Hepcidin Levels: A Prospective, Randomized, Blinded, Cross-Over Study Comparing Hemodialysis and Hemodiafiltration
by: Bergur V. Stefánsson, et al.
Published: (2012-03-01)

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients
by: Mi Yeon Jung, et al.
Published: (2015-03-01)

Variability in Hemoglobin Levels and the Factors Associated with Mortality in Hemodialysis Patients: A 78-Month Follow-Up Study
by: Natalino Salgado Filho, et al.
Published: (2021-01-01)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
by: Hiroki Kobayashi, et al.
Published: (2015-05-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Application of innovative hemocytometric parameters and algorithms for improvement of microcytic anemia discrimination
by: Margreet Schoorl, et al.
Published: (2015-06-01)

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis
by: Ramponi F, et al.
Published: (2016-09-01)

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients
by: Chie Ogawa, et al.
Published: (2020-09-01)

Correlation of serum leptin with levels of hemoglobin in hemodialysis
by: Rafieian-Kopaei Mahmoud, et al.
Published: (2012-04-01)

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
by: Besarab Anatole, et al.
Published: (2012-08-01)

Early continuous dialysis in acute glyphosate-surfactant poisoning
by: Knežević Violeta, et al.
Published: (2012-01-01)

CORRECTING OF ANEMIA USING IRON SUCROSE IN PATIENTS WITH CHRONIC KIDNEYDISEASE STAGE VD ON HEMODIALYSIS
by: I. Dudar, et al.
Published: (2014-08-01)

Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies
by: Daniela Boehm, et al.
Published: (2014-12-01)

Anemia and the use of antihypertensive medications in hemodialysis patients: multicenter retrospective observational study
by: N. Stepanova, et al.
Published: (2019-02-01)

Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients
by: Yu Ho Lee, et al.
Published: (2020-03-01)

Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis
by: Zhang ZY, et al.
Published: (2021-01-01)

Postdialysis serum sodium changes and systolic blood pressure in patients undergoing online hemodiafiltration and high-flux hemodialysis
by: Kyu Sig Hwang, et al.
Published: (2013-06-01)

CLINICAL AND ECONOMIC ANALYSIS OF USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR THE TREATMENT OF ANEMIA CKD V HD PATIENTS
by: M. Kolesnyk, et al.
Published: (2015-08-01)

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
by: Kristina Petrulienė, et al.
Published: (2017-01-01)

High dose ESAs are associated with high iPTH levels in hemodialysis patients with end-stage kidney disease: a retrospective analysis
by: Lan eChen, et al.
Published: (2015-11-01)

Comparison of intradialytic plasma volume change between online hemodiafiltration and standard hemodialysis
by: Masayuki Tanemoto, et al.
Published: (2018-11-01)

Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
by: Anak Agung Ngurah Putra Riana Prasetya, et al.
Published: (2021-01-01)

Comparison of Hemodialysis Using a Medium Cutoff Dialyzer versus Hemodiafiltration: A Controlled Cross-Over Study
by: Lindgren A, et al.
Published: (2020-10-01)

Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis—A Case Report and Review of the Literature
by: Verena Gotta, et al.
Published: (2020-06-01)

Gender differences in dose of erythropoietin to maintain hemoglobin target in hemodialysis patients
by: J A Coronado Daza, et al.
Published: (2019-01-01)

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1
by: Alberto Martínez-Castelao, et al.
Published: (2015-03-01)

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1
by: Alberto Martínez-Castelao, et al.
Published: (2015-03-01)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
by: Hamid Nasri
Published: (2013-01-01)

USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASES V D ST
by: M. Kolesnyk, et al.
Published: (2014-11-01)

Impact of hepcidin, interleukin 6, and other inflammatory markers with respect to erythropoietin on anemia in chronic hemodialysis patients
by: Ihab A. Ibrahim, et al.
Published: (2014-01-01)

Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients
by: Orăsan Olga Hilda, et al.
Published: (2017-10-01)

Blood leptin levels and erythropoietin requirement in Iranian hemodialysis patients
by: Rahimi A, et al.
Published: (2008-12-01)

Dose-dependent effect of continuous erythropoietin receptor activator on cardiac autonomic nervous activity and cardiovascular events in patients treated with online hemodiafiltration
by: N. M. Stepanova, et al.
Published: (2019-06-01)

Soluble transferrin receptor as a marker of erythropoiesis in patients undergoing high-flux hemodialysis
by: Pei Yin, et al.
Published: (2017-11-01)

Association of Erythropoietin, Adiponectin and Leptin levels with Anemia in uremic diabetic patients (Under hemodialysis):
by: Salim M. Al-Rubaâe, et al.
Published: (2011-01-01)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
by: Maoujoud O, et al.
Published: (2016-02-01)

Erythropoietin, erythropoiesis, and malarial anemia : the mechanisms and implications of insufficient erythropoiesis during murine blood-stage malaria
by: Chang, Kai-Hsin, 1974-
Published: (2003)